Case_id: case_68
Case_description: 
A 57-year-old female with a past medical history of alcoholism presents to the emergency room vomiting bright red blood. She is accompanied by her partner, who reports that she had been complaining of black and tarry stools for the past several days. Vital signs are temperature 37 degrees celsius, heart rate 141 beats per minute, blood pressure 90/60, respiratory rate 20, and oxygen saturation 99% on room air. On physical examination, she has splenomegaly and a positive fluid wave. The remainder of her examination is within normal limits. The patient is stabilized with intravenous fluids, and her blood pressure improves. Subsequent emergent upper endoscopy reveals bleeding from the submucosal veins in the lower 1/3 of the esophagus, but no gastric bleed. In the endoscopy suite she also receives IV octreotide. After intervention and resolution of her acute bleed, which of the following pharmacologic agents is indicated?
Options: 
1. Phentolamine
2. Prazosin
3. Nifedipine
4. Nadalol
5. Doxazosin
Correct Answer: Nadalol

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 4 (Nadalol)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**
- **Patient Information:** A 57-year-old female with a history of alcoholism.
- **Chief Complaint:** Vomiting bright red blood (hematemesis) and black, tarry stools (melena) over the past several days.
- **Vital Signs:** Tachycardia (HR 141 bpm), hypotension (BP 90/60 mmHg), normal temperature (37°C), respiratory rate of 20, and oxygen saturation of 99% on room air.
- **Physical Examination:** Splenomegaly and a positive fluid wave indicating ascites. No other significant findings.
- **Clinical Course:** Stabilized with intravenous fluids; emergent upper endoscopy revealed bleeding from submucosal veins in the lower third of the esophagus (esophageal varices). No gastric source of bleeding was identified. The patient received IV octreotide during the procedure, and the acute bleed was resolved.

**2. Analysis of Clinical Features**
- **Gastrointestinal Bleeding:** The presence of hematemesis and melena suggests an upper gastrointestinal (GI) bleed. The endoscopy findings of bleeding from submucosal veins in the lower third of the esophagus are indicative of esophageal varices.
- **Portal Hypertension Indicators:** Splenomegaly and ascites are clinical signs consistent with portal hypertension, which is often a consequence of liver cirrhosis, a condition frequently associated with chronic alcoholism.
- **Hemodynamic Stability:** Initial presentation with tachycardia and hypotension reflects the acute blood loss. Stabilization with fluids and improvement in blood pressure indicate effective initial management.
- **Treatment Administered:** IV octreotide, a vasoactive agent, is appropriate for acute variceal bleeding as it reduces portal blood flow and variceal pressure.

**3. Differential Diagnosis Analysis**
- **Option 1: Phentolamine**  
  - **Mechanism:** Non-selective alpha-adrenergic antagonist.
  - **Indication:** Primarily used in the management of hypertensive emergencies, especially pheochromocytoma.
  - **Relevance:** Not indicated for prevention of variceal rebleeding.
  
- **Option 2: Prazosin**  
  - **Mechanism:** Selective alpha-1 adrenergic blocker.
  - **Indication:** Primarily used for hypertension and sometimes for benign prostatic hyperplasia.
  - **Relevance:** Not indicated for portal hypertension or variceal bleeding prophylaxis.
  
- **Option 3: Nifedipine**  
  - **Mechanism:** Calcium channel blocker.
  - **Indication:** Used for hypertension and angina.
  - **Relevance:** Not indicated for portal hypertension or variceal bleeding prophylaxis.
  
- **Option 4: Nadolol**  
  - **Mechanism:** Non-selective beta-blocker.
  - **Indication:** Used to lower portal hypertension by decreasing cardiac output and causing splanchnic vasoconstriction, thereby reducing the risk of variceal rebleeding.
  - **Relevance:** Directly indicated for secondary prophylaxis of esophageal variceal bleeding.
  
- **Option 5: Doxazosin**  
  - **Mechanism:** Selective alpha-1 adrenergic blocker.
  - **Indication:** Primarily used for hypertension and benign prostatic hyperplasia.
  - **Relevance:** Not indicated for portal hypertension or variceal bleeding prophylaxis.

**4. Final Selection**
**My final selection is: Option 4 (Nadolol)(纳多洛尔)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 4 (Nadalol)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A 57-year-old female with alcoholism presents with acute hematemesis (vomiting bright red blood) and melena (black, tarry stools) for several days.  
- Vital signs show tachycardia (HR 141 bpm) and hypotension (BP 90/60 mmHg), improving after IV fluids.  
- Physical exam reveals splenomegaly and a positive fluid wave (indicative of ascites).  
- Upper endoscopy confirms bleeding from submucosal veins in the lower esophageal third (esophageal varices), with no gastric source.  

**2. Analysis of Clinical Features**  
- **Alcoholism**: A key risk factor for liver cirrhosis, which is the most common cause of portal hypertension and esophageal varices.  
- **Hematemesis and melena**: Indicate upper gastrointestinal bleeding, with esophageal varices as the confirmed source.  
- **Splenomegaly and ascites**: Strongly suggest decompensated cirrhosis (Child-Pugh class B or C), given the presence of two complications of portal hypertension.  
- **Endoscopy findings**: Bleeding from submucosal veins in the lower esophagus confirms variceal rupture. The absence of gastric bleeding rules out other sources like peptic ulcers.  

**3. Differential Diagnosis Analysis**  
- **Option 1: Phentolamine (α₁-blocker)**:  
  - Used acutely to reduce portal pressure via systemic vasodilation. However, it is typically administered as an infusion during active bleeding. Since the bleed is resolved, phentolamine is not indicated for long-term prophylaxis.  

- **Option 2: Prazosin (α₁-blocker)**:  
  - An oral α₁-blocker used for hypertension. It is not effective for portal hypertension management in this context.  

- **Option 3: Nifedipine (calcium channel blocker)**:  
  -曾 used for portal hypertension but associated with severe hypotension. It is no longer recommended due to safety concerns.  

- **Option 4: Nadolol (non-selective β-blocker)**:  
  - First-line for secondary prophylaxis of variceal bleeding in **compensated cirrhosis** by reducing portal pressure. However, in **decompensated cirrhosis** (ascites present), β-blockers are used cautiously with nitrates. Despite the patient’s ascites, nadolol is still a valid option when combined with clinical monitoring.  

- **Option 5: Doxazosin (α₁-blocker)**:  
  - Similar to prazosin, it is not indicated for portal hypertension management.  

**4. Final Selection**  
**My final selection is: Option 4 (Nadolol)(那多洛尔)**  

**Key Evidence Supporting the Choice:**  
- **Non-selective β-blockers (e.g., nadolol)** are the cornerstone of secondary prophylaxis for variceal bleeding in cirrhosis.  
- While decompensated cirrhosis (ascites) requires caution, guidelines still recommend β-blockers **in combination with nitrates** (e.g., isosorbide mononitrate). Since nitrate options are not listed, nadolol alone remains the most appropriate available choice, provided it is used with close monitoring.  
- Other options (α-blockers, nifedipine) lack evidence for efficacy or safety in this context.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 4 (Nadalol)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient Profile**: 57-year-old female with a history of **alcoholism**, presenting with **hematemesis** (bright red blood) and **melena** (black, tarry stools) for several days.  
- **Vital Signs**: Tachycardia (HR 141), hypotension (BP 90/60), resolved with IV fluids.  
- **Physical Exam**: **Splenomegaly** and **positive fluid wave** (indicative of ascites).  
- **Endoscopy Findings**: Bleeding from **submucosal veins in the lower esophagus** (esophageal varices), no gastric bleed. Treated with IV octreotide.  

**Decisive Features**:  
- Hematemesis + melena + esophageal varices → **variceal hemorrhage**.  
- Alcoholism + splenomegaly + ascites → **cirrhosis with portal hypertension**.  

---

**2. Analysis of Clinical Features**  
- **Timeline**: Chronic alcoholism likely led to cirrhosis, portal hypertension, and esophageal varices. Acute decompensation manifested as variceal bleeding.  
- **Key Relationships**:  
  - Portal hypertension → splenomegaly, ascites (fluid wave), and esophageal varices.  
  - Variceal rupture → upper GI bleeding (hematemesis/melena).  
- **Supporting Evidence**:  
  - Endoscopy confirms variceal bleed (submucosal veins in esophagus).  
  - Octreotide use aligns with acute variceal bleeding management (reduces portal pressure).  

---

**3. Differential Diagnosis Analysis**  
1. **Phentolamine** (Alpha-blocker): Used for hypertensive crises (e.g., pheochromocytoma). Irrelevant here.  
2. **Prazosin** (Alpha-1 blocker): Reduces blood pressure but exacerbates portal hypertension via splanchnic vasodilation. **Contraindicated**.  
3. **Nifedipine** (Calcium channel blocker): No role in portal hypertension; may worsen hypotension.  
4. **Nadalol** (Non-selective beta-blocker, NSBB): Reduces portal pressure by decreasing cardiac output (β1-blockade) and splanchnic vasoconstriction (β2-blockade). **First-line for secondary prophylaxis of variceal bleeding**.  
5. **Doxazosin** (Alpha-1 blocker): Similar to prazosin; harmful in cirrhosis.  

**Guideline Alignment**:  
- NSBBs (e.g., nadolol, propranolol) ± endoscopic band ligation are standard for preventing variceal rebleeding (AASLD/ACG guidelines).  

---

**4. Final Selection**  
**My final selection is: Option 4 (Nadalol) (纳多洛尔)**  
- **Key Evidence**:  
  1. Nadalol is a **non-selective beta-blocker** that reduces portal hypertension, preventing variceal rebleeding.  
  2. First-line for secondary prophylaxis post-acute variceal hemorrhage.  
  3. Other options (alpha-blockers, CCBs) lack efficacy or worsen outcomes in cirrhosis.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 4 (Nadalol)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option4

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option4 - Nadalol
Correct Answer: - Nadalol

Is the final diagnosis correct? ✓ Correct

